Ron Rogers

Jolie Mastectomy Fuels Debate on Breast Cancer Treatment

Angelina Jolie’s decision to have a double mastectomy is fueling debate among the thousands of women at risk of developing breast cancer who want to know how, if and when to have their breasts removed.

Jolie Has Double Mastectomy to Thwart Cancer Gene Risk

Angelina Jolie, named the highest- paid actress in Hollywood by Forbes in 2011, said she had a double mastectomy after learning she has a gene mutation linked to breast cancer, the disease that killed her mother at age 56.

Google, Merck, Gruyere, Newzbin2: Intellectual Property

Google Inc. owes its creation partly to a patented software algorithm for ranking documents in a database, issued to company founder Larry Page and owned by Stanford University.

Merck Wins Ruling to Block Mylan’s Copy of Zetia, Vytorin

Merck & Co. won a U.S. appeals court ruling that will prevent Mylan Inc. from selling a generic version of the Zetia and Vytorin cholesterol medicines before April 2017.

Merck to Pay $688 Million to Settle Vytorin Litigation

Merck & Co. said it will pay $688 million to resolve class-action litigation claiming it defrauded shareholders by withholding adverse results of a clinical trial of the anti-cholesterol drugs Vytorin and Zetia.

Merck, Circle, Mattel, Rosetta Stone: Intellectual Property

Merck & Co. is close to settling patent lawsuits against Teva Pharmaceutical Industries Ltd. over a generic version of the cholesterol drug Vytorin, according to a federal court document.

Merck Unit’s Plea Over Vioxx Investigation Accepted by Judge

A unit of Merck & Co., the second- largest U.S. drugmaker, pleaded guilty to a criminal misdemeanor charge as part of a $950 million settlement of a U.S. government probe of its illegal marketing of the painkiller Vioxx.

Merck, Teva Near Settlement Over Vytorin Copy, Records Show

Merck & Co. is close to settling patent lawsuits against Teva Pharmaceutical Industries Ltd. over a generic version of the cholesterol drug Vytorin, according to a federal court document.

Teva Won’t Sell Generic Vytorin for Cholesterol Until 2017 Under Accord

Teva Pharmaceutical Industries Ltd. agreed that it won’t sell generic versions of the cholesterol drugs Vytorin and Zetia until 2017, settling patent lawsuits with Merck & Co., court records show.

Madoff, Halliburton, Wells Fargo in Court News

Irving Picard, the trustee overseeing the bankruptcy of Bernard Madoff’s investment firm, spent $26.9 million in the six months ended Sept. 30 while recovering $849,000 for victims of Madoff’s Ponzi scheme, according to a report filed in Manhattan federal court.

"The appellate court appropriately upheld the lower court's ruling in April 2012 that found the patent for Zetia and Vytorin is valid and enforceable."

- Ron Rogers on Feb 07, 2013

Newark

New Jersey

Washington

Massachusetts

Yen Jumps Most in Three Weeks on Government Concern; Rand Slides

Tumblr’s 26-Year-Old Founder Celebrates $1.1 Billion Deal

U.S. Stocks Fluctuate as Investors Weigh Stimulus Timing

Yahoo Buys Tumblr for $1.1 Billion in Mayer's  Biggest Deal

S&P 500 Slips From Record as Yen Rebounds, Silver Gains